(1) All medical laboratory personnel and special analysts in Tennessee must hold current Tennessee licensure, unless specifically exempt by statute or rules promulgated by the Board.
(2) No person shall act as a medical laboratory director, supervisor, technologist, technician, laboratory trainee or a special analyst and accept a specimen for laboratory examination unless such person has obtained a license and is registered to act in such capacity by the board; provided, that this section shall not apply to pathologists certified or eligible for certification by the American Board of Pathology, or any other person recognized by the board as having special qualifications and who is duly licensed and registered to practice medicine in the state of Tennessee.
Use of Titles - Any person who possesses a valid, unsuspended and unrevoked license issued by the Board has the right to use the title or acronym that represents being a medical laboratory director (Ph.D), medical laboratory technologist (M.T.), medical laboratory technician (M.L.T.) or special analyst (S.A.) as defined in T.C.A. § 68-29-103
, or the title or acronym that represents being a cytotechnologist (C.T.) as defined in rule 1200-06-01-.01
. Violation of this rule regarding use of titles shall constitute unethical conduct and subject the licensee to disciplinary action.
The following personnel are exempt from the licensure requirements imposed pursuant to the "Tennessee Medical Laboratory Act":
All personnel performing the testing described in rule 1200-06-03-.02(5)
in the laboratory or portion of the otherwise licensed laboratory exempted from licensure pursuant to that rule.
Tenn. Comp. R. & Regs. 1200-06-01-.03
Original rule filed May 3, 1995; effective July 17, 1995. Amendment filed August 25, 2003; effective November 8, 2003. Amendment filed March 16, 2007; effective May 30, 2007. Amendment filed April 1, 2009; effective June 15, 2009.
Authority: T.C.A. §§ 4-5-202, 4-5-204, 63-1-102, 68-29-103, 68-29-104, 68-29-105, 68-29-116, 68-29-127, and 68-29-129.